Harvard Medical School article features GCTx

Harvard Medical School describes how GCTx is tackling COVID-19 utilizing our TFome cell engineering technology

Learn More

Previous
Previous

GCTx technology published in Nature Biotechnology

Next
Next

Biogen awarded GCTx Golden Ticket